顺铂在胰腺癌中的活性。
Activity of cisplatin in adenocarcinoma of the pancreas.
作者信息
Wils J A, Kok T, Wagener D J, Selleslags J, Duez N
机构信息
Department of Oncology, Laurentius Hospital, Rotterdam, The Netherlands.
出版信息
Eur J Cancer. 1993;29A(2):203-4. doi: 10.1016/0959-8049(93)90175-f.
PMID:8422283
Abstract
The activity of cisplatin in metastatic adenocarcinoma of the pancreas was assessed in 33 patients. Cisplatin was administered in a dose of 100 mg/m2, every 4 weeks. There were 2 complete responses and 5 partial responses (a response rate of 21%). The median duration of response was 5 months (range, 2+ to 15 months). Cisplatin is a modestly active drug in advanced pancreatic cancer.
摘要
对33例胰腺转移性腺癌患者评估了顺铂的活性。顺铂以100mg/m²的剂量给药，每4周一次。有2例完全缓解和5例部分缓解（缓解率为21%）。缓解的中位持续时间为5个月（范围为2+至15个月）。顺铂在晚期胰腺癌中是一种活性中等的药物。
Zotero 插件